Literature DB >> 11134593

Lysosomal augmentation during aminoglycoside uptake in cochlear hair cells.

E Hashino1, M Shero, R J Salvi.   

Abstract

Aminoglycoside antibiotics, such as kanamycin, have ototoxic side effects, which often result in degeneration of cochlear and vestibular hair cells in the inner ear. Cytotoxic effects of aminoglycosides, however, do not appear immediately after cellular uptake of aminoglycosides. In order to understand the mechanisms responsible for the delayed emergence of aminoglycoside ototoxicity, changes in lysosomal activities in cochlear hair cells were evaluated during a repeated administration of kanamycin by two methods. Electron microscopic localization of acid phosphatase (AcPase) revealed that AcPase started to accumulate in vesicles 27 h after the start of kanamycin administration. In addition, the number and size of AcPase-filled vesicles increased with repeated kanamycin doses. Confocal microscopic localization of the LysoTracker probe, a vital lysosomal marker, showed an increase in the size of lysosomes in hair cells that were treated with kanamycin. The temporal changes in the augmentation of lysosomes paralleled those in intracellular kanamycin levels. These results suggest that the intralysosomal compartments can accumulate extensive amounts of aminoglycosides, which might lead to lysosomal swelling and subsequent rupture.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11134593     DOI: 10.1016/s0006-8993(00)02971-1

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  10 in total

1.  Comparative analysis of combination kanamycin-furosemide versus kanamycin alone in the mouse cochlea.

Authors:  Keiko Hirose; Eisuke Sato
Journal:  Hear Res       Date:  2010-10-31       Impact factor: 3.208

Review 2.  Aminoglycoside- and Cisplatin-Induced Ototoxicity: Mechanisms and Otoprotective Strategies.

Authors:  Corné J Kros; Peter S Steyger
Journal:  Cold Spring Harb Perspect Med       Date:  2019-11-01       Impact factor: 6.915

Review 3.  Intracellular mechanisms of aminoglycoside-induced cytotoxicity.

Authors:  Takatoshi Karasawa; Peter S Steyger
Journal:  Integr Biol (Camb)       Date:  2011-07-29       Impact factor: 2.192

4.  Mechanisms of rapid sensory hair-cell death following co-administration of gentamicin and ethacrynic acid.

Authors:  Dalian Ding; Haiyan Jiang; Richard J Salvi
Journal:  Hear Res       Date:  2009-08-26       Impact factor: 3.208

5.  Quantitative justification for target concentration intervention--parameter variability and predictive performance using population pharmacokinetic models for aminoglycosides.

Authors:  Ivan Matthews; Carl Kirkpatrick; Nicholas Holford
Journal:  Br J Clin Pharmacol       Date:  2004-07       Impact factor: 4.335

6.  Uptake of gentamicin by bullfrog saccular hair cells in vitro.

Authors:  P S Steyger; S L Peters; J Rehling; A Hordichok; C F Dai
Journal:  J Assoc Res Otolaryngol       Date:  2003-11-12

7.  Uptake of fluorescent gentamicin by vertebrate sensory cells in vivo.

Authors:  C F Dai; D Mangiardi; D A Cotanche; P S Steyger
Journal:  Hear Res       Date:  2006-02-08       Impact factor: 3.208

Review 8.  Towards the Prevention of Aminoglycoside-Related Hearing Loss.

Authors:  Mary E O'Sullivan; Adela Perez; Randy Lin; Autefeh Sajjadi; Anthony J Ricci; Alan G Cheng
Journal:  Front Cell Neurosci       Date:  2017-10-18       Impact factor: 5.505

9.  Inflammation up-regulates cochlear expression of TRPV1 to potentiate drug-induced hearing loss.

Authors:  Meiyan Jiang; Hongzhe Li; Anastasiya Johnson; Takatoshi Karasawa; Yuan Zhang; William B Meier; Farshid Taghizadeh; Allan Kachelmeier; Peter S Steyger
Journal:  Sci Adv       Date:  2019-07-17       Impact factor: 14.136

10.  Different uptake of gentamicin through TRPV1 and TRPV4 channels determines cochlear hair cell vulnerability.

Authors:  Jeong-Han Lee; Channy Park; Se-Jin Kim; Hyung-Jin Kim; Gi-Su Oh; AiHua Shen; Hong-Seob So; Raekil Park
Journal:  Exp Mol Med       Date:  2013-03-08       Impact factor: 8.718

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.